Subscribe
Volodymyr_Kyrylyuk / Shutterstock.com
4 April 2024NewsMedtechMarisa Woutersen

Microsoft prevails in 3D medical imaging tech dispute

The Federal Circuit upholds a ruling in favour of Microsoft against an Orlando tech company | Dispute concerned 3D medical imaging technology | Court affirms PTAB’s decision to invalidate most of the patent.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Microsoft partners with Nordic data science firm on AI project
13 September 2022   Deal set to enable faster use of artificial intelligence in drug discovery | Planned AI models to identify novel targets and establish biomarkers of disease.
Americas
Microsoft’s AI software unit shakes off patent suit
12 July 2022   A Delaware court found in favour of the AI company, which Microsoft bought for $16 billion last year.


Editor's picks

Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024

Editor's picks

Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024
Asia
President Xi sends message to AIPPI’s World Congress
22 October 2024
Unified Patent Court
‘Every CMS filing is painful’: Notes from a Unified Patent Court dispute
26 September 2024
Unified Patent Court
Interview: Klaus Grabinski, UPC Court of Appeal president
24 September 2024
Unified Patent Court
‘Be prepared, and don’t assume at the UPC’: Christopher Stothers
12 September 2024
Unified Patent Court
Does the UPC offer a fresh take on patent validity?
5 September 2024

More on this story

Americas
Microsoft partners with Nordic data science firm on AI project
13 September 2022   Deal set to enable faster use of artificial intelligence in drug discovery | Planned AI models to identify novel targets and establish biomarkers of disease.
Americas
Microsoft’s AI software unit shakes off patent suit
12 July 2022   A Delaware court found in favour of the AI company, which Microsoft bought for $16 billion last year.

More on this story

Americas
Microsoft partners with Nordic data science firm on AI project
13 September 2022   Deal set to enable faster use of artificial intelligence in drug discovery | Planned AI models to identify novel targets and establish biomarkers of disease.
Americas
Microsoft’s AI software unit shakes off patent suit
12 July 2022   A Delaware court found in favour of the AI company, which Microsoft bought for $16 billion last year.

More features

Sandoz lands reduced antitrust award of $70m
New president’s to-do list: Patent bills, non-competes, USPTO director?
Sanofi subsidiary fends off $450m trade secrets case
Regulatory expert joins White & Case
Teva faces $500m fine for antitrust breaches over MS drug
UK Budget: A missed opportunity?
Pfizer infringed haemophilia therapy patent, says court
Cooley adds ex-Gowling partner